2024
Validation of the NCCN/Yale criteria for the identification of CDH1 pathogenic variant carriers.
Lerner B, Giner-Calabuig M, Carraway C, Richardson M, Krahn K, Susswein L, Nielsen S, Karam R, Xicola R, Llor X. Validation of the NCCN/Yale criteria for the identification of CDH1 pathogenic variant carriers. Journal Of Medical Genetics 2024, jmg-2024-110446. PMID: 39674581, DOI: 10.1136/jmg-2024-110446.Peer-Reviewed Original ResearchInternational Gastric Cancer Linkage ConsortiumInternational Gastric Cancer Linkage Consortium criteriaPV carriersLobular breast cancerGenetic tumor risk syndromesGenetic testingFamily membersEarly-onset diffuse gastric cancerPathogenic variant carriersGermline pathogenic variantsDiffuse gastric cancerPathogenic variantsEuropean Reference NetworkCancer geneticsRisk syndromeVariant carriersGenetics guidelinesEuropean cohortAutosomal-dominant syndromeBreast cancerCohortUS commercial laboratoryClinical dataGastric cancerCancer
2012
Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience
Castellví-Bel S, Ruiz-Ponte C, Fernández-Rozadilla C, Abulí A, Muñoz J, Bessa X, Brea-Fernández A, Ferro M, Giráldez MD, Xicola RM, Llor X, Jover R, Piqué JM, Andreu M, Castells A, Carracedo A, Association F. Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience. Mutagenesis 2012, 27: 153-159. PMID: 22294762, DOI: 10.1093/mutage/ger047.Peer-Reviewed Original ResearchConceptsPopulation-based colorectal cancer casesColorectal cancer casesExtensive clinical dataWhole-exome sequencingOncology GroupMulticentre studyColorectal cancerCRC casesControl subjectsFamilial CRCLynch syndromeCRC samplesCancer casesClinical dataFamilial historyCRC familiesGenetic susceptibility variantsCancerGenetic variantsPhase 1Pathways WntCandidate gene approachConsortium experienceSusceptibility variantsGenome-wide association studies